Literature DB >> 25790790

Regulation of antiviral T cell responses by type I interferons.

Josh Crouse1, Ulrich Kalinke2, Annette Oxenius1.   

Abstract

Type I interferons (IFNs) are pro-inflammatory cytokines that are rapidly induced in different cell types during viral infections. The consequences of type I IFN signalling include direct antiviral activity, innate immune cell activation and regulation of adaptive immune responses. In this Review, we discuss recent conceptual advances in our understanding of indirect and direct regulation of T cell immunity by type I IFNs, which can either promote or inhibit T cell activation, proliferation, differentiation and survival. This regulation depends, to a large extent, on the timing of type I IFN exposure relative to T cell receptor signalling. Type I IFNs also provide activated T cells with resistance to natural killer cell-mediated elimination.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25790790     DOI: 10.1038/nri3806

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  145 in total

1.  IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene.

Authors:  Meredith E Persky; Kenneth M Murphy; J David Farrar
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

2.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

3.  Type I interferon is required to mount an adaptive response to immunostimulatory DNA.

Authors:  J H Van Uden; C H Tran; D A Carson; E Raz
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

4.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

Authors:  Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2008-07-03       Impact factor: 31.745

5.  Bystander chronic infection negatively impacts development of CD8(+) T cell memory.

Authors:  Erietta Stelekati; Haina Shin; Travis A Doering; Douglas V Dolfi; Carly G Ziegler; Daniel P Beiting; Lucas Dawson; Jennifer Liboon; David Wolski; Mohammed-Alkhatim A Ali; Peter D Katsikis; Hao Shen; David S Roos; W Nicholas Haining; Georg M Lauer; E John Wherry
Journal:  Immunity       Date:  2014-05-15       Impact factor: 31.745

6.  Structural linkage between ligand discrimination and receptor activation by type I interferons.

Authors:  Christoph Thomas; Ignacio Moraga; Doron Levin; Peter O Krutzik; Yulia Podoplelova; Angelica Trejo; Choongho Lee; Ganit Yarden; Susan E Vleck; Jeffrey S Glenn; Garry P Nolan; Jacob Piehler; Gideon Schreiber; K Christopher Garcia
Journal:  Cell       Date:  2011-08-19       Impact factor: 41.582

7.  Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

Authors:  S M Santini; C Lapenta; M Logozzi; S Parlato; M Spada; T Di Pucchio; F Belardelli
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

Review 8.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

9.  Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.

Authors:  Myeong Sup Lee; Chan Hee Park; Yun Hee Jeong; Young-Joon Kim; Sang-Jun Ha
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

10.  Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

Authors:  Joseph A Fraietta; Yvonne M Mueller; Guibin Yang; Alina C Boesteanu; Donald T Gracias; Duc H Do; Jennifer L Hope; Noshin Kathuria; Shannon E McGettigan; Mark G Lewis; Luis D Giavedoni; Jeffrey M Jacobson; Peter D Katsikis
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  176 in total

1.  The long noncoding RNA Morrbid regulates CD8 T cells in response to viral infection.

Authors:  Jonathan J Kotzin; Fany Iseka; Jasmine Wright; Megha G Basavappa; Megan L Clark; Mohammed-Alkhatim Ali; Mohamed S Abdel-Hakeem; Tanner F Robertson; Walter K Mowel; Leonel Joannas; Vanessa D Neal; Sean P Spencer; Camille M Syrett; Montserrat C Anguera; Adam Williams; E John Wherry; Jorge Henao-Mejia
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

Review 2.  Trial Watch-Oncolytic viruses and cancer therapy.

Authors:  Jonathan Pol; Aitziber Buqué; Fernando Aranda; Norma Bloy; Isabelle Cremer; Alexander Eggermont; Philippe Erbs; Jitka Fucikova; Jérôme Galon; Jean-Marc Limacher; Xavier Preville; Catherine Sautès-Fridman; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-12-08       Impact factor: 8.110

Review 3.  Trial Watch-Immunostimulation with cytokines in cancer therapy.

Authors:  Erika Vacchelli; Fernando Aranda; Norma Bloy; Aitziber Buqué; Isabelle Cremer; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-12-08       Impact factor: 8.110

Review 4.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

5.  Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.

Authors:  Liang Cheng; Haisheng Yu; Guangming Li; Feng Li; Jianping Ma; Jingyun Li; Liqun Chi; Liguo Zhang; Lishan Su
Journal:  JCI Insight       Date:  2017-06-15

Review 6.  Genetics of systemic sclerosis.

Authors:  Lara Bossini-Castillo; Elena López-Isac; Maureen D Mayes; Javier Martín
Journal:  Semin Immunopathol       Date:  2015-06-02       Impact factor: 9.623

7.  Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Authors:  Magar Ghazarian; Xavier S Revelo; Mark K Nøhr; Helen Luck; Kejing Zeng; Helena Lei; Sue Tsai; Stephanie A Schroer; Yoo Jin Park; Melissa Hui Yen Chng; Lei Shen; June Ann D'Angelo; Peter Horton; William C Chapman; Diane Brockmeier; Minna Woo; Edgar G Engleman; Oyedele Adeyi; Naoto Hirano; Tianru Jin; Adam J Gehring; Shawn Winer; Daniel A Winer
Journal:  Sci Immunol       Date:  2017-04-21

8.  Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.

Authors:  Marc Beyer; Zeinab Abdullah; Jens M Chemnitz; Daniela Maisel; Jil Sander; Clara Lehmann; Yasser Thabet; Prashant V Shinde; Lisa Schmidleithner; Maren Köhne; Jonel Trebicka; Robert Schierwagen; Andrea Hofmann; Alexey Popov; Karl S Lang; Annette Oxenius; Thorsten Buch; Christian Kurts; Mathias Heikenwalder; Gerd Fätkenheuer; Philipp A Lang; Pia Hartmann; Percy A Knolle; Joachim L Schultze
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

9.  Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.

Authors:  Liang Cheng; Jianping Ma; Jingyun Li; Dan Li; Guangming Li; Feng Li; Qing Zhang; Haisheng Yu; Fumihiko Yasui; Chaobaihui Ye; Li-Chung Tsao; Zhiyuan Hu; Lishan Su; Liguo Zhang
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

10.  Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines.

Authors:  Karlhans Fru Che; Riitta Kaarteenaho; Elisa Lappi-Blanco; Bettina Levänen; Jitong Sun; Åsa Wheelock; Lena Palmberg; C Magnus Sköld; Anders Lindén
Journal:  Mol Med       Date:  2017-08-29       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.